Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Helen Pearce
96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Related publications
Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
New England Journal of Medicine
Medicine
Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Early Markers of Tubular Dysfunction in Antiretroviral-Experienced HIV-Infected Patients Treated With Tenofovir Versus Abacavir
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
Differential Effects of Tenofovir/Emtricitabine and Abacavir/Lamivudine on Human Leukocyte Recruitment
Antiviral Therapy
Infectious Diseases
Pharmacology
Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Effects of Highly Active Antiretroviral Therapy on Platelet Activating Factor Metabolism in Naïve HIV-Infected Patients: II) Study of the Abacavir/Lamivudine/Efavirenz Haart Regimen
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections With Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
